International Journal of Clinical Research

Objective To analyze the medical value of using sacubitril valsartan sodium tablets in the treatment of hypertension patients. Methods A total of 90 hypertensive patients who received treatment between January 2022 and December 2023 were included in the experimental study. Then, they were randomly divided into a control group of 45 patients who received valsartan treatment and an observation group of 45 patients who received combined treatment with sacubitril and valsartan sodium tablets. Compare the therapeutic value of blood pressure and adverse reactions before and after treatment under different nursing medication differences. Results Before treatment, there was no statistically significant difference in blood pressure indicators between the two groups of patients (P>0.05). After treatment, the blood pressure indicators in the observation group were better than those in the control group, with statistical significance (P<0.05), but there was no statistical significance in the comparison of adverse reactions (P>0.05). Conclusion Sacubitril valsartan sodium tablets have a good therapeutic effect on hypertension, with no serious adverse reactions and high medication safety.

Sacubitril Valsartan Sodium Tablets; hypertension; Valsartan; Targeting organs; Security